FDA Drug recall D-1123-2014
Methotrexate Intraocular 400mcg 0.1cc
- FDA Drug
- Class II
- terminated
- Published 2014-03-12
On 2014-03-12 the FDA classified a Class II recall of Methotrexate Intraocular 400mcg 0.1cc by Natures Pharmacy And Compounding Center, citing lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a….
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1123-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-11-01 |
| Published | 2014-03-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Natures Pharmacy And Compounding Center |
| Distribution | NC |
Product
Methotrexate Intraocular 400mcg 0.1cc
Reason
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Identifiers
| code_info | All lot numbers within expiry. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1123-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.